Vaccines and immunotherapies have changed the face of health care. Biomaterials offer the
ability to improve upon these medical technologies through increased control of the types …

Abstract Interleukin-27 (IL-27) is a new member of the IL-12 family. It is produced by
activated antigen-presenting cells and plays an important role in the regulation of CD4+ T …

Aims Activation of cannabinoid receptor 2 (CB 2R) has been reported to ameliorate the
pathogenesis of experimental autoimmune encephalomyelitis (EAE). In this study, we …

Inflammasomes are multiprotein complexes that can sense pathogen‐associated molecular
patterns and damage‐associated molecular signals. They are involved in the initiation and …

The development of nanoparticles (NPs) with potential therapeutic uses represents an area
of vast interest in the scientific community during the last years. Recently, the pandemic …

Altered immune responses associated with human disease conditions, such as inflammatory
and infectious diseases, cancers, and autoimmune diseases, are among the primary causes …

IL-23 is a heterodimeric pro-inflammatory cytokine secreted by dendritic cells and
macrophages that belongs to the IL-12 family. It has pro-inflammatory effects and is a key …

Using nanostructured drug delivery systems has attracted increasing interest in
immunotherapeutic approaches. The intrinsic immunomodulatory properties and versatility …

Interleukin-38 (IL-38), a new cytokine of interleukin-1 family (IL-1F), is expressed in the
human heart, kidney, skin, etc. Recently, new evidence indicated that IL-38 is involved in the …

Aims To evaluate whether activating α7 nicotinic acetylcholine receptor (α7n AC hR) could
inhibit the NOD‐like receptor family, pyrin domain containing 3 (NLRP 3) inflammasome …